Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Syndax Pharmaceuticals Inc has filed 653 SEC EDGAR filings since 06 Apr 2007

SEC filing history

Showing 526-550 of 652 matching filings.

Per page
25
Current page
22
4

PRIMARY DOCUMENT

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37708

FORM 8-K

Filing date
19 May 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37708

FORM 8-K

Filing date
08 May 2017
Reporting date
08 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-217172

EFFECT filing

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
12 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37708

DEFINITIVE ADDITIONAL MATERIALS

Filing date
07 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37708

DEFINITIVE PROXY STATEMENT

Filing date
07 Apr 2017
Reporting date
17 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-217172

S-3

Filing date
06 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37708

FORM 8-K

Filing date
04 Apr 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
31 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37708

8-K

Filing date
02 Mar 2017
Reporting date
02 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Feb 2017
Reporting date
13 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89449

SC 13G/A filing

Filing date
14 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89449

SC 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89449

SEC SCHEDULE 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37708

8-K

Filing date
09 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .